Gene Transfer Clinical Study in Crigler-Najjar Syndrome

NCT03223194 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Crigler-Najjar Syndrome

Interventions

GENETIC: AT342

Sponsor

Audentes Therapeutics